Poland· PL-100395001

Finomel Peri

A lösungen zur parenteralen ernährung, kombinationen product containing produkt złożony, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFinomel PeriATCB05BA10REGISTER NO.PL-100395001PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Produkt złożony
Manufacturer
Baxter Polska Sp. z o.o.
Country
Poland (PL)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991402884
  • gtin
    05909991402877
  • gtin
    05909991402860

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/88d1dab1-4d39-4089-b854-f4c1d26639b6
GET /v1/drugs/88d1dab1-4d39-4089-b854-f4c1d26639b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsja do infuzji",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909991402884 ¦ Rp ¦ 132559\n4 worki 2020 ml\n05909991402877 ¦ Rp ¦ 132560\n4 worki 1450 ml\n05909991402860 ¦ Rp ¦ 132561\n4 worki 1085 ml",
  "substance": "Alaninum 20,70 g/L + Arginina 11,5 g/L + Glicyna 10,3 g/L + Histidinum 4,8 g/L + izoleucyna 6 g/L + Leucinum 7,3 g/L + lizyny chlorowodorek 7,25 g/L + Methioninum 4 g/L + fenyloalanina 5,6 g/L + prolina 6,8 g/L + Serinum 5 g/L + Treoninum 4,2 g/L + Tryptophanum 1,8 g/L + Tyrosinum 0,4 g/L + Valinum 5,8 g/L + Natrii acetas trihydratas 5,62 g/L + potasu chlorek 4,48 g/L + wapnia chlorek dwuwodny 0,74 g/L + Magnezu siarczan siedmiowodny 2,47 g/L + Natrii glycerophosphas hydricus 5,92 g/L + Zinci sulphas heptahydricus 0,023 g/L + Glucosum 130 g/L + Oleum sojae purificatum 60 g/L + Olivae oleum raffinatum 50 g/L + Triglicerydy nasyconych kwasów tłuszczowych o średniej długości łańcucha 50 g/L + Olej rybny, bogaty w omega-3-kwasy 40 g/L",
  "common_name": "Produkt złożony",
  "pl_product_id": "100395001",
  "pozwolenie_nr": "25327",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.